GlaxoSmithKline

China’ action against British executive may prompt firms to rethink their investments

Chinese police's action against a British executive of GlaxoSmithKline Plc might cause some international companies to rethink their investment plans in the country.

Region: 
Companies: 
General: 
People: 

Former GSK China head & others charged with corruption

Pharmaceuticals giant GlaxoSmithKline Plc's (GSK's) former China head Mark Reilly and two of his colleagues have been charged with corruption by Chinese police.

Business: 
Region: 
Companies: 
General: 
People: 

GSK the UK drug company faces charges for bribing Polish doctors

GlaxoSmithKline which is the largest drug company of UK supposedly bribed some doctors and now is going through a criminal investigation case in Poland, BBC Panorama has revealed.

Today some fresh evidences revealed that the money which was used for bribing was supposed to be spent on educating patients.

Companies: 
General: 

Despite Q4 losses, GSK may buy back shares

GlaxoSmithKline (GSK) Limited is expected to resume its share buyback programme on Thursday despite loss due to a massive legal charge in the fourth quarter. The investors who had urged GSK to adopt ‘giving cash back’ decision of other major drug companies would greatly welcome this move.

According to Thomson Reuters estimation the giant British drugmaker is believed to reveal its forecast to record a loss of around 6 pence a share in its 2010 results.

Companies: 
General: 

New Drug for Lupus Shown Green Signal by FDA Advisory Panel

GlaxoSmithKline's drug Benlysta has shown green signal by an advisory panel of the US Food and Drug Administration for its experimental use for the treatment of disease lupus in US.

It is for the first time in past 50 years that a medicine in the class of drugs for treating lupus has been approved. The ultimate decision on the commercialization of the drug from the FDA would come on December 9.

Companies: 
General: 

Pages

Subscribe to RSS - GlaxoSmithKline